AC Immune and J&J Advance Tau-Targeting Alzheimer’s Vaccine

Encouraging Early Efficacy Signs

 
• By Andrew McConaghie
  
AC Immune
AC Immune has suffered two setbacks to its Alzheimer's pipeline this year, but is moving ahead with its novel vaccination candidate. • Source: Shutterstock

More from Neurological

More from Therapy Areas